Article -> Article Details
Title | Atrial Fibrillation Market Outlook, Analysis, Key Players, Opportunities and Forecast |
---|---|
Category | Fitness Health --> Health Articles |
Meta Keywords | Atrial Fibrillation Market, Atrial Fibrillation Market Size, Atrial Fibrillation Market Industry, Global Atrial Fibrillation Market, Atrial Fibrillation Market Research, Atrial Fibrillation Market Analysis, |
Owner | Vaibhav |
Description | |
Atrial fibrillation is a disorder of the pace or the rhythm of the
heart. It is caused by unsystematic electrical activity in the atria of the
heart, which causes rapid stimulus of the ventricles, leading to an irregular
heartbeat. Numerous factors such as advancements in minimally invasive
surgeries to treat atrial fibrillation, appropriate and timely intervention of
the healthcare delivery systems, and increased incidence rates of the risk
factors are expected to drive the growth of the market during the forecast
period. Atrial
Fibrillation Market Share is expected to reach USD
3,470.85 Million at a CAGR 13.30% during the forecast period of 2022-2030 The global atrial fibrillation market is currently dominated by many
market players. The key players in the market are engaged in new product
launches and strategic collaborations to strengthen its market position. For
instance, in January 2017, Abbott completed the acquisition of St. Jude
Medical, Inc. St. Jude Medical's strong positions in fast-growing areas such as
atrial fibrillation, heart failure, structural heart and chronic pain balance
Abbott's leading positions in coronary interventions and mitral valve disease
and will further create a strong and diverse product portfolio. Major Key
Players: Some of Key Players are
Medtronic Plc, Johnson & Johnson Services, Inc., Abbott, Boston Scientific
Corporation, MicroPort Scientific Corporation, Biotronik SE & Co. KG,
Koninklijke Philips N.V., AtriCure, Inc., CardioFocus, Osypka AG, Siemens AG,
Biosense Webster, Inc., Sichuan Jinjiang Electronic Science and Technology Co.,
Ltd., CathRx Ltd., and Vanguard AG. Segment Analysis The global Atrial Fibrillation Market Outlook
By type, treatment, and end-user. The atrial fibrillation devices market, on the
basis of type, has been segmented into paroxysmal atrial fibrillation,
persistent atrial fibrillation, and permanent atrial fibrillation. The permanent type of atrial fibrillation is
anticipated to hold the largest share as it is the most common type of AFib
with a high occurrence rate. The persistent atrial fibrillation segment is
estimated to be the fastest growing owing to increased recurrence rates in
patients. The market, on the basis of treatment, has been
segmented into medications, non-surgical procedures, and surgical procedures. The market, based on medications, has been segmented
blood thinners, rate controllers, and rhythm controllers. The market, based on non-surgical procedures, has
been segmented into electrical cardioversion and catheter ablation. The market, based on surgical procedures, has been
segmented into pacemaker implantation and open-heart maze procedure. Regional Analysis The market in the Americas is
expected to dominate the global atrial fibrillation market during the forecast
period due to the escalation in the adoption of advanced technologies and
procedures for the treatment of atrial fibrillation, and well-developed
healthcare infrastructure. According to the Centers for Disease Control and
Prevention in 2017, an estimated 2.7–6.1 million people in the United States
have atrial fibrillation (AFib). The European market is expected to be the
second-largest due to government funding and support of the healthcare sector.
Also, many companies are setting up their research and development centers in
this region, which will boost the market growth in this region. Moreover, the
market in Asia-Pacific is anticipated to be the fastest-growing during the
assessment period owing to growing disposable income, and huge population
susceptible to cardiovascular diseases. The market in the Middle East &
Africa is likely to account for the smallest share of the global atrial
fibrillation market. About Market Research
Future At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services. MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market
segments, enable our clients to see more, know more, and do more, which help to
answer all their most important questions. In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members. Contact us: Market Research Future
(part of Wantstats Research and Media Private Limited), 99 Hudson Street, 5Th Floor, New York, New York 10013 United States of America +1 646 845 9312 |